1. Home
  2. PRPO vs ICCT Comparison

PRPO vs ICCT Comparison

Compare PRPO & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • ICCT
  • Stock Information
  • Founded
  • PRPO N/A
  • ICCT 1992
  • Country
  • PRPO United States
  • ICCT United States
  • Employees
  • PRPO N/A
  • ICCT N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • PRPO Industrials
  • ICCT Technology
  • Exchange
  • PRPO Nasdaq
  • ICCT Nasdaq
  • Market Cap
  • PRPO 8.8M
  • ICCT 9.1M
  • IPO Year
  • PRPO N/A
  • ICCT N/A
  • Fundamental
  • Price
  • PRPO $4.44
  • ICCT $0.82
  • Analyst Decision
  • PRPO
  • ICCT
  • Analyst Count
  • PRPO 0
  • ICCT 0
  • Target Price
  • PRPO N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • PRPO 5.9K
  • ICCT 26.9K
  • Earning Date
  • PRPO 08-15-2024
  • ICCT 08-08-2024
  • Dividend Yield
  • PRPO N/A
  • ICCT N/A
  • EPS Growth
  • PRPO N/A
  • ICCT N/A
  • EPS
  • PRPO N/A
  • ICCT N/A
  • Revenue
  • PRPO $15,812,000.00
  • ICCT $9,034,579.00
  • Revenue This Year
  • PRPO $75.18
  • ICCT N/A
  • Revenue Next Year
  • PRPO N/A
  • ICCT N/A
  • P/E Ratio
  • PRPO N/A
  • ICCT N/A
  • Revenue Growth
  • PRPO 61.64
  • ICCT 16.06
  • 52 Week Low
  • PRPO $4.31
  • ICCT $0.81
  • 52 Week High
  • PRPO $8.99
  • ICCT $10.60
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 29.52
  • ICCT 40.28
  • Support Level
  • PRPO $4.31
  • ICCT $0.81
  • Resistance Level
  • PRPO $5.12
  • ICCT $0.90
  • Average True Range (ATR)
  • PRPO 0.37
  • ICCT 0.07
  • MACD
  • PRPO -0.03
  • ICCT -0.00
  • Stochastic Oscillator
  • PRPO 10.74
  • ICCT 8.40

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: